該報告顯(xian)示，全球制(zhi)藥(yao)(yao)行業排名前五的國家是(shi)美(mei)國、中國、瑞(rui)士、英(ying)國和(he)德國，中國已(yi)經進(jin)入(ru)全球制(zhi)藥(yao)(yao)第二梯隊。

相比2020年(nian)千強中(zhong)(zhong)國(guo)上榜208家，2021年(nian)中(zhong)(zhong)國(guo)醫藥企業(ye)數量同比增長19.71%。入(ru)圍的中(zhong)(zhong)國(guo)企業(ye)中(zhong)(zhong)，前五名為恒瑞(rui)(rui)醫藥、石藥集(ji)團(tuan)、齊(qi)魯(lu)制藥、揚子江藥業(ye)、片仔癀。其中(zhong)(zhong)，恒瑞(rui)(rui)醫藥已連續兩年(nian)在中(zhong)(zhong)國(guo)入(ru)榜藥企中(zhong)(zhong)排(pai)名第(di)一。

此外，入(ru)圍前(qian)100強的中國藥(yao)(yao)(yao)(yao)企共20家。分別為(wei)：恒瑞醫藥(yao)(yao)(yao)(yao)排名(ming)(ming)(ming)(ming)第(di)(di)(di)(di)(di)(di)24名(ming)(ming)(ming)(ming)，石藥(yao)(yao)(yao)(yao)集團排名(ming)(ming)(ming)(ming)第(di)(di)(di)(di)(di)(di)25名(ming)(ming)(ming)(ming)，齊魯(lu)制藥(yao)(yao)(yao)(yao)第(di)(di)(di)(di)(di)(di)26名(ming)(ming)(ming)(ming)，揚子江藥(yao)(yao)(yao)(yao)業第(di)(di)(di)(di)(di)(di)28名(ming)(ming)(ming)(ming)，片(pian)仔癀第(di)(di)(di)(di)(di)(di)33名(ming)(ming)(ming)(ming)，智飛生物第(di)(di)(di)(di)(di)(di)36名(ming)(ming)(ming)(ming)，百濟(ji)神州第(di)(di)(di)(di)(di)(di)38名(ming)(ming)(ming)(ming)，復星醫藥(yao)(yao)(yao)(yao)第(di)(di)(di)(di)(di)(di)53名(ming)(ming)(ming)(ming)，愛(ai)美客第(di)(di)(di)(di)(di)(di)54名(ming)(ming)(ming)(ming)，長(chang)春生物第(di)(di)(di)(di)(di)(di)57名(ming)(ming)(ming)(ming)，科倫藥(yao)(yao)(yao)(yao)業第(di)(di)(di)(di)(di)(di)59名(ming)(ming)(ming)(ming)，濟(ji)民可信(xin)第(di)(di)(di)(di)(di)(di)60名(ming)(ming)(ming)(ming)，中國生物制藥(yao)(yao)(yao)(yao)第(di)(di)(di)(di)(di)(di)67名(ming)(ming)(ming)(ming)，云南白(bai)藥(yao)(yao)(yao)(yao)第(di)(di)(di)(di)(di)(di)71名(ming)(ming)(ming)(ming)，沃森(sen)生物第(di)(di)(di)(di)(di)(di)74名(ming)(ming)(ming)(ming)，信(xin)達生物第(di)(di)(di)(di)(di)(di)77名(ming)(ming)(ming)(ming)，康泰(tai)生物第(di)(di)(di)(di)(di)(di)78，豪森(sen)藥(yao)(yao)(yao)(yao)業第(di)(di)(di)(di)(di)(di)82名(ming)(ming)(ming)(ming)，上海醫藥(yao)(yao)(yao)(yao)第(di)(di)(di)(di)(di)(di)88名(ming)(ming)(ming)(ming)，華東醫藥(yao)(yao)(yao)(yao)第(di)(di)(di)(di)(di)(di)92名(ming)(ming)(ming)(ming)。